About Curia
Curia is a Healthcare company based in Albany (United States) founded in 1991, and was acquired by Aledade in February 2023. Drug research, development, testing, and consulting services are provided. It operates on a Professional Services and Managed Services model. The company has 11 employees. Curia has completed 7 acquisitions, including ComGenex, Curia and Euticals. Its website curiaglobal.com draws about 30 thousand monthly visits. Its Indian entity Curia India Private Limited reported revenue of ₹283 Cr. Curia offers products and services including Small Molecule Services, Generic APIs, Biologics Services, and Sterile Drug Product. Its focus areas include Pharmaceuticals and Contract Development and Manufacturing. Its competitors include Catalent, Surrozen and AmplifyBio; 2 of its 3 listed competitors have raised funding.
Company details
Curia is established as a leading global contract development and manufacturing organization (CDMO) with over 30 years of experience in the pharmaceutical and biopharmaceutical sectors. Services are provided across small molecules, generic APIs, and biologics, encompassing drug discovery, development, and manufacturing. Solutions are tailored to meet complex challenges through a network of 23 facilities across North America, Europe, and India. Advanced technologies and dedicated teams are utilized to ensure flexibility and scalability, accelerating the delivery of therapies to patients. Expertise is backed by deep scientific knowledge and a commitment to quality and collaboration.
- Headquarters Albany, United States
- Employees 11
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website curiaglobal.com
- Social LinkedIn X Facebook
- Acquired by Aledade (Feb 2023)
- Legal Name Curia Global, Inc.
- Date of Incorporation 25 Jan, 2005
- Jurisdiction Hyderabad, Telangana, India
Associated legal entities of Curia
Curia operates through Curia India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Curia India Private Limited CIN U73200TG2005PTC045178 | Active | 25 Jan 2005 | Hyderabad, Telangana | ₹283 Cr | 11 | 6 | View details |
Products & Services of Curia
Curia offers a comprehensive portfolio of products and services, including Small Molecule Services, Generic APIs, Biologics Services, and Sterile Drug Product.
Services for small molecule drug discovery and manufacturing.
Comprehensive capabilities for generic API discovery and manufacturing.
Expert services in biologics discovery and sterile manufacturing.
Development and manufacturing services for sterile drug products.
Funding Insights of Curia
- Total Rounds 2
- Last Round Grant — $961,212
- First Round $100,000
(Oct 1999)
- Investors Count 2
All 2 funding rounds of Curia with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2021 | $961,212 | Grant | – | – | |
| Oct 1999 | $100,000 | Grant | – | – |
3 investors in total: 3 institutional.
Investors in Curia
Curia has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Aledade, SBIR and Ministry of Economy, Finance and Industrial and Digital Sovereignty.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| economie.gouv.fr | ||||
Federal innovation and scientific achievement services are provided. | 1982 | sbir.gov | Lithia Springs, United States | |
Primary care physician platform for patient care delivery is provided. | 2014 | aledade.com | Bethesda, United States |
Investor details for Curia
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Curia India Private Limited (Curia)
Curia India Private Limited is the primary company behind Curia. The board of Curia India Private Limited currently have 5 directors; the longest-serving is Murali Krishna Valluri, appointed in 2016. 23 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Murali Krishna Valluri DIN 07598186 | Whole-time director | 21 Dec 2016 | 9 yrs 10 mo | Curia India Private Limited |
| Mariesa Beth Coppola DIN 07862947 | Director | 13 Dec 2017 | 8 yrs 10 mo | Curia India Private Limited |
| James Francis Grabowski Jr DIN 07862855 | Director | 15 Dec 2021 | 4 yrs 10 mo | Curia India Private Limited |
| Manoj Deo Dorlikar DIN 09844876 | Whole-time director | 12 Jul 2023 | 3 yrs 3 mo | Curia India Private Limited |
| Satyanarayana Tummanapalli DIN 01913723 | Whole-Time Director | 18 Sep 2025 | 1 yr 1 mo | Curia India Private Limited |
People of Curia
268 people are tracked at Curia (99 in leadership, 169 in team); the tracked headcount is 11.
| Name | Role | Group |
|---|---|---|
Steve Lichter | President, API | Leadership |
Grant Carr | Vice President, Global R&d Drug Discovery Site Head, Buffalo | Leadership |
Eva Gajate | Operations Director | Leadership |
Mark Wolf | Director, Medicinal Chemistry | Leadership |
Sean Ballou | Senior Director Quality Assurance | Leadership |
Rebecca Alcantara | Director, Global Supplier Quality & Compliance | Leadership |
Geno Worke | Senior Director Of Operations | Leadership |
Kristine Shepherd Cqm/Oe | Director Of Quality | Leadership |
Barb Baldwin | Supply Chain Director | Leadership |
Philip Macnabb | CEO | Leadership |
Jeffrey Stowe | Director Project Engineering | Leadership |
Roberto Salghetti Drioli | EU Quality Operations Director (api, DP And R&d Sites) | Leadership |
Ganesh Kamath | VP Of Finance, Sales Operations And Development | Leadership |
Steven Schneider | Senior Director Generic Sales API | Leadership |
Simonetta Conti | Head Of Regulatory Affairs Italy And France | Leadership |
Michelle Dellefave | Associate Director, IT - Quality Systems | Leadership |
Michel Desbordes | Head Of Production | Leadership |
Faten Shawwa | Site Quality Head | Leadership |
Adam Harshman | Tax Director | Leadership |
Carrie A. Costello | Senior Director PMO And Customer Service, Small Molecule | Leadership |
248 more people are available in the full profile.
Complete people profiles for Curia
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Curia
Figures of Curia India Private Limited, the primary company behind Curia, for FY 2025. Revenue was ₹283 Cr (+23% year on year). Net profit was ₹40.04 Cr (14% margin). EBITDA was ₹69.58 Cr (25% margin). Revenue has grown at a compounded annual rate of +2% over three years and +16% over five years.
- ₹283 CrRevenue · FY 2025 · +23% YoY
- ₹40.04 CrNet profit · 14% margin
- ₹69.58 CrEBITDA · 25% margin
- ₹49.78 CrPaid-up capital
- 11Employees (provident fund records)
- +2%Revenue CAGR, 3 years
- +16%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Curia India Private Limited are on its company page.
Detailed financial statements for Curia
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Curia
Curia has strategically engaged in corporate development activities, having acquired 7 companies. Notable acquisitions include ComGenex, Curia and Euticals.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Provider of drug discovery on molecular biology, viral vectors and cell & protein engineering | lakepharma.com | Belmont, United States | 2009 | Jul 2021 | •••• | |
Contract developer and manufacturer of formulation and GMP filling of biologics | integritybio.com | Camarillo, United States | 2003 | Jul 2021 | •••• | |
APIs, custom synthesis, and fine chemicals are developed and manufactured. | euticals.com | Milano, Italy | 1984 | May 2016 | $358M | |
Material testing services in analytical chemistry are provided. | whitehouselabs.com | Hunterdon, United States | 2000 | Dec 2015 | $56M | |
CMO specializing in injectables and lyophilized biological and pharmaceutical products | osobio.com | Albuquerque, United States | 2008 | Jun 2014 | $110M | |
Drug research and development services for rare diseases are provided. | cedarburgpharma.com | Grafton, United States | 1998 | Mar 2014 | $41M | |
Computational chemistry services for drug discovery are provided. | comgenex.hu | Budapest, Hungary | 1992 | Jan 2006 | •••• |
Complete acquisition details for Curia
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Curia
14 dated milestones of Curia across 36 years, from founding to its latest funding, stage changes and deals.
- IPO Lists on the stock exchange (IPO).
- Founded Curia is founded.
- Funding First funding round of $100K.
- Acquisition Acquires ComGenex.
- Acquisition Acquires Curia.
- Acquisition Acquires Curia.
- Acquisition Acquires Curia.
- Acquisition Acquires OsoBio.
- Acquisition Acquires Whitehouse Laboratories.
- Acquisition Acquires Euticals.
- Funding Latest funding round, Grant, of $961K.
- Acquisition Acquires Integrity Bio.
- Acquisition Acquires LakePharma.
- Exit Acquired by Aledade.
Competitors of Curia
Curia has 3 listed competitors in our database, 2 of them funded. They include Catalent, Surrozen and AmplifyBio.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| catalent.com | 2007 | Somerset, United States | 9,390 | CDMO offering drug and biologics development services | ||
| surrozen.com | 2016 | San Francisco, United States | $133M | 80 | Selective Wnt agonists are developed for human tissue regeneration. | |
| amplify-bio.com | 2021 | Hilliard, United States | $229.75M | Provides contract research, development, and manufacturing services for biologic drugs. |
Detailed competitors of Curia
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Curia
The website of Curia (curiaglobal.com) receives about 29.7K visits a month and ranks #736,785 among all websites worldwide, #845 in Biotechnology and Pharmaceuticals.
- Monthly visits29.7K
▲ 22% vs previous month
- Unique visitors10.5K
per month
- Global rank#736,785
among all websites
- Category rank#845
Health · Biotechnology and Pharmaceuticals
- Bounce rate43%
- Pages per visit6.2
- Average visit1 min 05 sec
- DevicesDesktop 39% · Mobile 61%
Websites whose visitors overlap most with Curia. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| eikontx.com | 100% | 13.1K | #3,245,561 | View details | |
| pharm-int.com | 90% | 6.3K | #2,825,984 | View details | |
| argonautms.com | 90% | 9.6K | #2,712,987 | View details | |
| alloytx.com | 89% | 10.4K | #1,364,425 | View details | |
| patheon.com | 88% | 89.1K | #488,648 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 8 similar websites and full traffic analytics for Curia
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 8 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Curia (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Curia
Complete news archive for Curia
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Curia
Curia was founded in 1991 and raised its 1st funding round 8 years after it was founded.
Curia is headquartered in Albany, United States.
Curia has 11 employees.
The primary company behind Curia, Curia India Private Limited, reported revenue of ₹283 Cr for FY 2025, up 23% year on year.
Curia is established as a leading global contract development and manufacturing organization (CDMO) with over 30 years of experience in the pharmaceutical and biopharmaceutical sectors. Services are provided across small molecules, generic APIs, and biologics, encompassing drug discovery, development, and manufacturing. Solutions are tailored to meet complex challenges through a network of 23 facilities across North America, Europe, and India. Advanced technologies and dedicated teams are utilized to ensure flexibility and scalability, accelerating the delivery of therapies to patients. Expertise is backed by deep scientific knowledge and a commitment to quality and collaboration.
Curia's top competitors include Surrozen, Catalent and AmplifyBio.
Curia offers Small Molecule Services, Generic APIs, Biologics Services, and Sterile Drug Product.
Curia operates through Curia India Private Limited.
Yes. Curia was acquired by Aledade in February 2023.
The legal entities of Curia currently have 6 directors, including Murali Krishna Valluri, James Francis Grabowski Jr, Mariesa Beth Coppola and others.